Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    CG-4801

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
    Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

    09 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/09/3058308/18362/en/Amarin-Confirms-Effective-Date-for-1-For-20-ADS-Ratio-Change.html

    GLOBENEWSWIRE
    09 Apr 2025
    Share Share
    Amarin Shares Data On EPA In Lp(a) Plasma, GLP-1 Combination
    Amarin Shares Data On EPA In Lp(a) Plasma, GLP-1 Combination

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052239/18362/en/Amarin-Highlights-Recent-Data-Presented-at-ACC-25-Evaluating-Mechanistic-Effects-of-Eicosapentaenoic-Acid-EPA-in-Lp-a-Enriched-Plasma-and-in-Combination-with-GLP-1-Agonist.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Study: EPA & GLP-1 Effects On Lp(a) To Be Presented At ACC
    Study: EPA & GLP-1 Effects On Lp(a) To Be Presented At ACC

    19 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/19/3045269/18362/en/New-Research-Exploring-Mechanistic-Benefits-of-Eicosapentaenoic-Acid-EPA-In-Vitro-on-Lipoprotein-a-Lp-a-Oxidation-and-on-Protein-Expression-in-Endothelial-Cells-in-Combination-with.html

    GLOBENEWSWIRE
    19 Mar 2025
    Share Share
    Amarin Plans ADR Ratio Change Under Its Depository Receipt Program
    Amarin Plans ADR Ratio Change Under Its Depository Receipt Program

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041242/18362/en/Amarin-Announces-Plan-to-Initiate-a-Ratio-Change-Under-Its-American-Depository-Receipt-ADR-Program.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    Amarin Reports Q4 Results, Business Update, Announces Corporate Action
    Amarin Reports Q4 Results, Business Update, Announces Corporate Action

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041230/18362/en/Amarin-Reports-Fourth-Quarter-Financial-Results-Business-Update-and-Announces-Important-Corporate-Action.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033894/18362/en/Amarin-Marks-Key-Milestone-for-VASCEPA-VAZKEPA-Icosapent-Ethyl-Publication-of-Post-Hoc-Analysis-of-REDUCE-IT-in-Journal-of-the-American-Heart-Association-Reports-Benefit-on-Top-of-.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share